Vasopressin-mediated protein phosphorylation in intact toad urinary bladder

Area of Science:

• Cellular Physiology
• Molecular Endocrinology
• Renal Physiology

Background:

• Arginine vasopressin (AVP) is a key hormone regulating water reabsorption in the kidney.
• Protein phosphorylation is a critical post-translational modification involved in signal transduction pathways.
• Understanding AVP's molecular targets is essential for elucidating its physiological effects.

Purpose of the Study:

• To investigate the effects of AVP on endogenous protein phosphorylation in toad bladders.
• To identify specific phosphoproteins modulated by AVP during the hydroosmotic response.
• To explore the role of cyclic AMP in mediating AVP-induced phosphorylation changes.

Main Methods:

• Utilized 32P-labeled intact toad bladders to examine protein phosphorylation.
• Administered arginine vasopressin (AVP) and a cyclic AMP analog (8-(p-chloro-phenylthio)-cyclic AMP).
• Investigated AVP effects in the presence and absence of an osmotic gradient using isolated epithelial cells and an AVP antagonist.

Main Results:

• AVP increased 32P incorporation into proteins with molecular weights of 17,000, 28,000, and 34,000.
• AVP decreased 32P incorporation into a 15,500 MW protein, an effect dependent on the osmotic gradient.
• Cyclic AMP analog mimicked AVP's effects; phosphorylation changes were specific to the bladder epithelium and blocked by an antagonist.

Conclusions:

• AVP-stimulated protein phosphorylation, particularly of 17,000 and 34,000 MW proteins, is a key event in toad bladder function.
• Cyclic AMP-dependent phosphorylation likely mediates some physiological effects of AVP.
• The decrease in phosphorylation of the 15,500 MW protein is linked to the hydroosmotic response itself.